The Food and Drugs Authority (FDA) has arrested two people over the manufacture and distribution of falsified ‘Dr Alfred Capsules’, a dietary supplement marketed for male vitality on social media.
The FDA said the products had been adulterated with Sildenafil citrate, a prescription-only drug substance which was not declared on the product label.
In a public release dated September 9, 2026, the FDA said the capsules had not been registered by the Authority.
The FDA said following regulatory intelligence and enforcement operations, it had identified an organised syndicate operating in Accra and Suhum and involved in the manufacture and distribution of the falsified products across the country.
The two suspects are currently on police enquiry bail and assisting with investigations.
The FDA said the falsified capsules were produced in unauthorised, unregulated and unhygienic environments and posed a public health risk.
Laboratory analysis conducted by the FDA’s Centre for Laboratory Services and Research (CLSR) confirmed the presence of Sildenafil citrate in the falsified capsules.
Sildenafil citrate is a Phosphodiesterase Type 5 (PDE5) inhibitor and a prescription-only medicine used to treat erectile dysfunction in men and pulmonary arterial hypertension.
The FDA said the genuine product was manufactured by CV Al Manar Herbafit of Jalan Imogiri, Bantul, DI Yogyakarta, Indonesia, and registered in Ghana by Unateus Ghana Limited as a food supplement.
The Authority stressed that the registered product does not contain Sildenafil citrate.
The FDA said there were several differences between the registered product and the falsified versions.
The registered product comes in a pack of 30 capsules and uses high-quality container material, with clear text alignment and secure packaging.
The falsified product uses lower-quality container material, has poor print resolution and blurred or altered lettering, and comes in packs of either 30 or 60 capsules.
The registered product also carries clear and traceable batch numbers which match on the label and the base of the container.
The falsified versions either have no matching batch numbers or carry fictitious FDA registration numbers.
The registered product also has uniform tamper-evident sealing and an aluminium inner seal which is removed when the bottle is first opened.
The falsified versions lack safety seals on the bottle caps and may or may not have an aluminium inner seal.
The genuine capsules have a standard wine-red shell containing uniform off-white fine powder.
The falsified versions have different shell colours, including transparent and black and red, and contain greenish-brown powder.
The FDA urged members of the public to be cautious when buying the product through social media platforms and to report suspected cases of falsified medicines and food supplements.
Members of the public may contact the FDA via WhatsApp or call 0551112224/5, email [
